NYXH Nyxoah

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares

REGULATED INFORMATION

Information on the total number of voting rights and shares

Mont-Saint-Guibert (Belgium), July 29, 2025, 10:45 pm CET / 4:45 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.

  • Share capital: EUR 6,432,066.28
  • Total number of securities carrying voting rights: 37,441,140 (all ordinary shares)
  • Total number of voting rights (= denominator): 37,441,140 (all relating to ordinary shares)
  • Number of rights to subscribe to securities carrying voting rights not yet issued: 2,793,941 (all granted subscription rights; this number excludes 493,057 subscription rights that were issued but not yet granted)

*

* *

Contact:

Nyxoah

John Landry, CFO

Attachment



EN
29/07/2025

Underlying

NYXHNyxoah

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE
Free
NYXH NYXOAH

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), July 29, 2025, 10:45 pm CET / 4:45 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 6,432,066.28 Total number of securities carrying voting rights: 37,441,140 (all ordinary shares) Total number of voting rights (= denominator): 37,4...

17h / 47m 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Informations sur le nombre total de droits de vote et d'actions

Informations sur le nombre total de droits de vote et d'actions INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 29 juillet 2025, 22:45h CET / 16:45h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publie les informations ci-dessous suite à l'émission de nouvelles actions. Capital: EUR 6.432.066,28 Nombre total de titres avec droits de vote: 37.441.140 (tous des actions ordinaires) Nombre total de droits d...

17h / 47m 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 1...

Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025 Nyxoah Publiera ses Résultats Financiers du Second Trimestre 2025 le 18 Août 2025 Mont-Saint-Guibert, Belgique – Mardi 29 juillet 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale développant des alternatives thérapeutiques révolutionnaires pour l'apnée obstructive du sommeil (AOS) par la neuromodulation, a annoncé aujourd'hui a annoncé aujourd'hui que la Société publiera ses résultats financiers pour le second trimestre...

18h / 2m 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, ...

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont-Saint-Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will release financial results for the second quarter of 2025 on Monday, August 18, 2025. Company management will host a conference call to discuss finan...

18h / 2m 1 EN
 PRESS RELEASE
Free
NYXH NYXOAH

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical...

Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Mont-Saint-Guibert, Belgium – July 28, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that data from its DREAM pivotal study was published online in the Journal of Clinical Sleep Medicine. The DREAM pivotal study presents comprehensive 1...

July 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch